Beating Heart Mitral Valve REPair With the HARPOON™ System: ReaL World Outcomes From a multICenter observATional European Registry
- Conditions
- Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse
- Registration Number
- DRKS00022785
- Lead Sponsor
- Harpoon Medical, an indirect wholly-owned subsidiary of Edwards Lifesciences Corporation, Edwards Lifesciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting stopped after recruiting started
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Subjects who are clinically suitable for treatment with the HARPOON™ System, as per the Instructions for Use (IFU), will be evaluated for inclusion in the registry.
Exclusion Criteria
N/A
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Freedom from re-operation due to recurrent severe mitral regurgitation through 1-year post-implant<br>
- Secondary Outcome Measures
Name Time Method